Your browser doesn't support javascript.
loading
Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease.
Kaasenbrood, Lotte; Ray, Kausik K; Boekholdt, S Matthijs; Smulders, Yvo M; LaRosa, John C; Kastelein, John J P; van der Graaf, Yolanda; Dorresteijn, Johannes A N; Visseren, Frank L J.
Affiliation
  • Kaasenbrood L; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Ray KK; Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK.
  • Boekholdt SM; Department of Cardiology, Academic Medical Centre, Amsterdam, The Netherlands.
  • Smulders YM; Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands.
  • LaRosa JC; SUNY Health Science Center, Brooklyn, New York, USA.
  • Kastelein JJP; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • van der Graaf Y; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Dorresteijn JAN; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Visseren FLJ; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.
Heart ; 104(20): 1699-1705, 2018 10.
Article in En | MEDLINE | ID: mdl-29622600

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Atorvastatin / PCSK9 Inhibitors Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Heart Journal subject: CARDIOLOGIA Year: 2018 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Atorvastatin / PCSK9 Inhibitors Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Heart Journal subject: CARDIOLOGIA Year: 2018 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom